论文信息 - First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models - 字舞流文

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

Fei Yang | F. Meric-Bernstam | L. Carvajal | Ming Zhao | C. Tapia | Xiaofeng Zheng | M. Aivado | A. Akcakanat | Jian-guo Ren | K. Evans | D. Sutton | V. Guerlavais | E. Dumbrava | Kurt W. Evans | E. Yuca | S. Pairawan | A. Annis | S. Santiago | Priya Subash Chandra Bose